[1] EBRAHIMZADEH LEYLABADLO H, GHOTASLOU R, SAMADI KAFIL H, et al. Non-alcoholic fatty liver diseases: From role of gut microbiota to microbial-based therapies[J]. European Journal of Clinical Microbiology & Infectious Dseases: Official Publication of the European Society of Clinical Microbiology, 2020, 39(4):613-627.
[2] 刘傲雪, 周翔海, 张秀英, 等.非酒精性脂肪肝的危险因素探讨[J].中国临床医生杂志, 2021,49(2):165-169.
LIU A X, ZHOU X H, ZHANG X Y, et al.Risk factors of nonalcoholic fatty liver [J].Chinese Journal for Clinicians, 2021,49(2):165-169.
[3] 张佳雯, 林水治, 李世洋, 等.食品功能性成分调控妊娠糖尿病的研究进展[J].食品与发酵工业, 2020,46(17):285-290.
ZHANG J W, LIN S Z, LI S Y, et al. Research progress on the gestational diabetes mellitus regulation by functional food ingredients[J]. Food and Fermentation Industries, 2020, 46(17):285-290.
[4] BUZZETTI E, PINZANI M, TSOCHATZIS E A.The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)[J].Metabolism, 2016,65(8):1 038-1 048.
[5] 全国脂肪肝与酒精性肝病研讨会,中国肝病协会,中国医学会脂肪肝专家委员会,中国医师协会.非酒精性脂肪性肝病防治指南(2018更新版)[J].传染病信息, 2018,31(5):393-402.
National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association Fatty Liver Expert Committee, Chinese Medical Doctor Association.Guidelines for the prevention and treatment of nonalcoholic fatty liver disease (2018 update) [J].Infectious disease information, 2018,31 (5):393-402.
[6] 耿妍, 鲁晓岚, 耿燕, 等.肠道菌群紊乱在大鼠非酒精性脂肪肝中的作用机制[J].分子诊断与治疗杂志, 2020,12(12):1 626-1 630.
GENG Y, LU X L, GENG Y, et al. Mechanism of intestinal flora disturbance in nonalcoholic fatty liver disease in rats[J]. Journal of Molecular Diagnostics and Therapy, 2020, 12(12):1 626-1 630.
[7] 孙之梅. 基于肝肠轴功能改变对非酒精性脂肪肝发病与治疗的研究[D].广州:广东药学院, 2014.
SUN Z M. The changes of liver-intestinal axis function promote the pathogenesis of nonalcoholic fatty liver disease[D]. Guangzhou: Guangdong Pharmaceutical University, 2014.
[8] 易艳容, 曾亚, 何佳, 等.非酒精性脂肪性肝病患者肠道菌群变化及双歧杆菌三联活菌胶囊对肠道菌群、肝功能、血脂及胰岛素抵抗的影响[J].中国肝脏病杂志(电子版), 2016,8(3):87-92.
YI Y R, ZENG Y, HE J, et al.Changes of intestinal flora in patients with non-alcoholic fatty liver disease and the effects of Bifidobacterium triple viable capsules on intestinal flora, liver function, blood lipid and insulin resistance [J].Chinese Journal of Liver Disease (Electronic Version), 2016,8 (3):87-92.
[9] 陈大卫, 梁娇娇, 程月, 等.鼠李糖乳杆菌hsryfm 1301发酵乳在非酒精性脂肪肝细胞模型中对人肝细胞L-02的益生作用[J].食品与发酵工业, 2021,47(11):61-67.
CHEN D W, LIANG J J, CHENG Y, et al. Probiotic function of Lactobacillus rhamnosus hsryfm 1301 fermented milk on human hepatocyte L-02 in NAFLD cell model[J]. Food and Fermentation Industries, 2021, 47(11):61-67.
[10] CANFORA E E, MEEX R C R, VENEMA K, et al.Gut microbial metabolites in obesity, NAFLD and T2DM[J].Nature Reviews Endocrinology, 2019,15(5):261-273.
[11] BO S, JIA Y M J, JIAN H, et al.Sodium butyrate ameliorates high-fat diet-induced NAFLD through PPARα-mediated activation of β oxidation and suppression of inflammation[J].Journal of Agricultural and Food Chemistry, 2018,66(29):7 633-7 642.
[12] SUN B, JIA Y, YANG S, et al.Sodium butyrate protects against high-fat diet-induced oxidative stress in rat liver by promoting expression of nuclear factor E2-related factor 2[J].The British Journal of Nutrition, 2019,122(4):400-410.
[13] 蒲俊宁, 王华杰, 陈代文, 等.饲粮直链/支链淀粉比对育肥猪生长性能、营养物质表观消化率、肠道食糜菌群数量与挥发性脂肪酸浓度以及肌内脂肪含量的影响[J].动物营养学报, 2018,30(12):4 874-4 885.
PU J N, WANG H J, CHEN D W, et al. Effects of dietary amylose/amylopectin ratio on growth performance, nutrient apparent dgestibility, intestinal microflora number and volatile fatty acid concentrations and intramuscular fat content of finishing pigs[J]. Chinese Journal of Animal Nutrition, 2018, 30(12):4 874-4 885.
[14] 张廷婷, 赵文颖, 谢倍珍, 等.黑木耳及其多糖对高脂饮食大鼠的降血脂和肠道菌群调节作用[J].中国食品学报, 2021,21(9):89-101.
ZHANG T T, ZHAO W Y, XIE B Z, et al. Effects of Auricularia auricula and its polysaccharides on hypolipidemic and regulating intestinal flora in high-fat diet rats[J]. Journal of Chinese Institute of Food Science and Technology, 2021, 21(9):89-101.
[15] 李可洲, 李宁, 黎介寿, 等.短链脂肪酸对大鼠移植小肠形态及功能的作用研究[J].世界华人消化杂志, 2002,10(6):720-722.
LI K Z, LI N, LI J S, et al.Effects of short chain fatty acids on the morphology and function of transplanted small intestine in rats [J].World Chinese Journal of Digestology, 2002,10(6):720-722.
[16] 徐懂, 尹美君, 王钰铭, 等.FXR-CYP7A1轴在胆汁淤积性肝病中的调控研究进展[J].中西医结合肝病杂志, 2021,31(5):470-473.
XU D, YIN M J, WANG Y M, et al.Research progress of fxr-cyp7a1 axis regulation in cholestatic liver disease[J].Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, 2021, 31(5):470-473.
[17] ALLEN K, JAESCHKE H, COPPLE B L. Bile acids induce inflammatory genes in hepatocytes: A novel mechanism of inflammation during obstructive cholestasis[J]. The American Journal of Pathology, 2011, 178(1):175-186.
[18] KEITEL V, DRÖGE C, HÄUSSINGER D. Targeting FXR in cholestasis[J]. Handbook of Experimental Pharmacology, 2019, 256:299-324.
[19] LI F, JIANG C T, KRAUSZ K W, et al.Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity[J].Nature Communications, 2013,4:2 384.
[20] CHEN Y, LI J H, WU Z R, et al.Computational insight into the allosteric activation mechanism of farnesoid X receptor[J].Journal of chemical information and modeling, 2020,60(3):1 540-1 550.
[21] RIDLON J M, HYLEMON P B.Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7α-dehydroxylating intestinal bacterium[J].Journal of Lipid Research, 2012,53(1):66-76.
[22] WANG K, LIAO M F, ZHOU N, et al.Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids[J].Cell Reports, 2019,26(1):222-235.
[23] ZHANG Y C, LICKTEIG A J, CSANAKY I L, et al.Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion[J].Toxicology and Applied Pharmacology, 2018,338:112-123.
[24] 况俊良, 郑晓皎, 赵爱华, 等.代谢性疾病中胆汁酸水平变化及相关治疗策略[J].上海交通大学学报(医学版), 2019,39(6):678-683.
KUANG J L, ZHENG X J, ZHAO A H, et al. Alterations in bile acid levels in metabolic diseases and related treatment strategies[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2019, 39(6):678-683.
[25] DE SMET I, DE BOEVER P, VERSTRAETE W.Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity[J].The British Journal of Nutrition, 1998,79(2):185-194.
[26] CHOW M D, LEE Y H, GUO G L.The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J].Molecular Aspects of Medicine, 2017,56:34-44.
[27] LI H, CHEN F, SHANG Q, et al. FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade[J]. American Journal of Physiology. Gastrointestinal and Liver Physiology, 2005, 288(1): G60-G66.
[28] 丁锐, 刘志洲, 庞立园, 等.菌群、乙醇代谢与急性酒精中毒的关系研究[J].中国微生态学杂志, 2016,28(11):1 346-1 348.
DING R, LIU Z Z, PANG L Y, et al. The relationship between microbiota, ethanol metabolism and acute alcohol intoxication[J]. Chinese Journal of Microecology, 2016, 28(11):1 346-1 348.
[29] CHARLTON M R, BURNS J M, PEDERSEN R A, et al.Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the united states[J].Gastroenterology, 2011,141(4):1 249-1 253.
[30] 褚君星. 肠道菌群和内源性酒精代谢在非酒精性脂肪性肝炎发生中的作用[D].石家庄:河北医科大学, 2014.
CHU J X. The role of gut microbiota and endogenous ethanol's metabolism in NASH[D]. Shijiazhuang: Hebei Medical University, 2014.
[31] SARC L, LIPNIK-STANGELJ M. Comparison of ethanol and acetaldehyde toxicity in rat astrocytes in primary culture[J]. Arhiv Za Higijenu Rada i Toksikologiju, 2009, 60(3):297-305.
[32] GOFF L M, COWLAND D E, HOOPER L, et al.Low glycaemic index diets and blood lipids:A systematic review and meta-analysis of randomised controlled trials[J].Nutrition, Metabolism and Cardiovascular Diseases, 2013,23(1):1-10.
[33] CHRISTENSEN E G, LICHT T R, KRISTENSEN M, et al.Bifidogenic effect of whole-grain wheat during a 12-week energy-restricted dietary intervention in postmenopausal women[J].European Journal of Clinical Nutrition, 2013,67(12):1 316-1 321.
[34] 谢宁. 两株乳酸杆菌对高脂饮食大鼠胆固醇影响及相关机制研究[D].长沙:中南大学, 2011.
Study of the cholesterol-lowering ability in vitro and in vivo of two lactobacilli strains and the related mechanisms[D]. Changsha: Central South University, 2011.
[35] 王晨, 钟赛意, 邹宇晓.膳食纤维经肠道微生态途径调节脂质代谢作用的研究进展[J].食品科学, 2019,40(3):338-347.
WANG C, ZHONG S Y, ZOU Y X. Dietary fiber regulates lipid metabolism through the gut microbiota: A literature review[J]. Food Science, 2019, 40(3):338-347.
[36] LI X, LEI S Z, LIU L, et al.Synergistic effect of Lotus seed resistant starch and short-chain fatty acids on mice fecal microbiota in vitro[J].International Journal of Biological Macromolecules, 2021,183(3):2 272-2 281.
[37] LEI S Z, LI X, LIU L, et al.Effect of Lotus seed resistant starch on tolerance of mice fecal microbiota to bile salt[J].International Journal of Biological Macromolecules, 2020,151:384-393.
[38] 王欣. RS4型甘薯抗性淀粉对高脂饮食小鼠炎症因子及PPAR-αmRNA表达的影响[D].雅安:四川农业大学, 2013.
WANG X. The effect of RS4-type sweet potato resistant starch on inflammatory cytokines and PPAR-α mRNA in mice fed a high-fat diet[D]. Ya′an: Sichuan Agricultural University, 2013.
[39] ZHOU D, CHEN Y W, ZHAO Z H, et al.Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression[J].Experimental & Molecular Medicine, 2018,50(12):1-12.
[40] YIN W L, BAIN S C, MIN T.The effect of glucagon-like peptide-1 receptor agonists on renal outcomes in type 2 diabetes[J].Diabetes Therapy:Research, Treatment and Education of Diabetes and Related Disorders, 2020,11(10):835-844.
[41] GIUBERTI G, GALLO A, MOSCHINI M, et al.New insight into the role of resistant starch in pig nutrition[J].Animal Feed Science and Technology, 2015,201:1-13.
[42] ZHANG C, QIU M Y, WANG T, et al.Preparation, structure characterization, and specific gut microbiota properties related to anti-hyperlipidemic action of type 3 resistant starch from Canna edulis[J].Food Chemistry, 2021,351:129340.
[43] ZENG H L, ZHENG Y X, LIN Y, et al.Effect of fractionated lotus seed resistant starch on proliferation of Bifidobacterium longum and Lactobacillus delbrueckii subsp.bulgaricus and its structural changes following fermentation[J].Food Chemistry, 2018,268:134-142.
[44] ARIBAS M, KAHRAMAN K, KOKSEL H.In vitro glycemic index, bile acid binding capacity and mineral bioavailability of spaghetti supplemented with resistant starch type 4 and wheat bran[J].Journal of Functional Foods, 2020,65:103778.
[45] ZHENG B, WANG T T, WANG H W, et al.Studies on nutritional intervention of rice starch- oleic acid complex (resistant starch type V) in rats fed by high-fat diet[J].Carbohydrate Polymers, 2020,246(1):116637.
[46] 刘雨. 益生菌联合姜黄素对非酒精性脂肪肝病大鼠肠道屏障及肠道菌群的实验研究[D].邯郸:河北工程大学, 2021.
LIU Y.Experimental study of probiotics combined with curcumin on intestinal barrier and intestinal flora of rats with non-alcoholic fatty liver disease[D].Handan:Hebei University of engineering, 2021.
[47] 金其荣, 徐勤.大豆低聚糖生产、生理功能及其应用[J].食品科学, 1994,15(11):7-12.
JIN Q R, XU Q.Production, physiological function and application of soybean oligosaccharides [J].Food science, 1994,15(11):7-12.
[48] LYE H S, RAHMAT-ALI G R, LIONG M T.Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract[J].International Dairy Journal, 2010,20(3):169-175.
[49] 薛文通, 王浩.功能性低聚糖—大豆低聚糖[J].食品研究与开发, 2003,24(3):3-5.
XUE W T, WANG H.Functional oligosaccharide soybean oligosaccharide [J].Food Research and Development, 2003,24(3):3-5.
[50] 于治中, 丁长河, 李里特.大豆低聚糖的生产、生理功能及其应用[J].中国食品添加剂, 2007(1):159-163;150.
YU Z Z, DING C H, LI L T.Production, physiological functions and applications of soybean oligosaccharide[J].China Food Additives, 2007(1):159-163;150.
